Wave Life Sciences Stock Analysis
| WVE Stock | USD 13.51 0.35 2.66% |
IPO Date 11th of November 2015 | 200 Day MA 9.3163 | 50 Day MA 14.661 | Beta (1.77) |
Wave Life Sciences holds a debt-to-equity ratio of 1.018. At present, Wave Life's Total Debt To Capitalization is projected to drop slightly based on the last few years of reporting. Wave Life's financial risk is the risk to Wave Life stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Wave Life's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Wave Life's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Wave Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Wave Life's stakeholders.
For many companies, including Wave Life, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Wave Life Sciences, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Wave Life's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 18.9117 | Enterprise Value Ebitda (10.12) | Price Sales 22.2613 | Shares Float 84.2 M | Wall Street Target Price 33.375 |
Wave Life Sciences is undervalued with Real Value of 17.74 and Target Price of 33.38. The main objective of Wave Life stock analysis is to determine its intrinsic value, which is an estimate of what Wave Life Sciences is worth, separate from its market price. There are two main types of Wave Life's stock analysis: fundamental analysis and technical analysis.
The Wave Life stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Wave Life's ongoing operational relationships across important fundamental and technical indicators.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. Wave Stock Analysis Notes
About 14.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.65. Wave Life Sciences had not issued any dividends in recent years. Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company was incorporated in 2012 and is based in Singapore. Wave Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 235 people. For more information please call MBA MD at 65 6236 3388 or visit https://wavelifesciences.com.Wave Life Sciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Wave Life's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Wave Life Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Wave Life Sciences is way too risky over 90 days horizon | |
| Wave Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 108.3 M. Reported Net Loss for the year was (97.01 M) with loss before taxes, overhead, and interest of (65.38 M). | |
| Wave Life Sciences has about 148.16 M in cash with (151.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
| Wave Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Over 86.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Angioplasty Balloons Market to Reach 3.6 Billion, Globally, by 2033 at 3.4 percent CAGR Allied Market Research |
Wave Largest EPS Surprises
Earnings surprises can significantly impact Wave Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.21 | -0.24 | -0.03 | 14 | ||
2025-05-07 | 2025-03-31 | -0.2556 | -0.29 | -0.0344 | 13 | ||
2025-07-30 | 2025-06-30 | -0.27 | -0.31 | -0.04 | 14 |
Wave Life Environmental, Social, and Governance (ESG) Scores
Wave Life's ESG score is a quantitative measure that evaluates Wave Life's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Wave Life's operations that may have significant financial implications and affect Wave Life's stock price as well as guide investors towards more socially responsible investments.
Wave Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Vanguard Group Inc | 2025-06-30 | 3.5 M | Loomis, Sayles & Company Lp | 2025-06-30 | 3.3 M | Emerald Advisers, Llc | 2025-06-30 | 3.3 M | Geode Capital Management, Llc | 2025-06-30 | 2.8 M | State Street Corp | 2025-06-30 | 2.8 M | Primecap Management Company | 2025-06-30 | 2.5 M | Artisan Partners Limited Partnership | 2025-06-30 | 2.3 M | Affinity Asset Advisors, Llc | 2025-06-30 | 2 M | Emerald Mutual Fund Advisers Trust | 2025-06-30 | 1.9 M | Ra Capital Management, Llc | 2025-06-30 | 18.2 M | Adage Capital Partners Gp Llc | 2025-06-30 | 15 M |
Wave Market Capitalization
The company currently falls under 'Mid-Cap' category with a total capitalization of 2.43 B.Wave Profitablity
The company has Net Profit Margin of (1.12) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (7.41) %, which entails that for every $100 of revenue, it lost $7.41.| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.26) | |
| Return On Capital Employed | (0.53) | (0.55) | |
| Return On Assets | (0.25) | (0.26) | |
| Return On Equity | (0.42) | (0.44) |
Management Efficiency
Wave Life Sciences has Return on Asset of (0.2833) % which means that on every $100 spent on assets, it lost $0.2833. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.8651) %, meaning that it generated no profit with money invested by stockholders. Wave Life's management efficiency ratios could be used to measure how well Wave Life manages its routine affairs as well as how well it operates its assets and liabilities. As of February 20, 2026, Return On Tangible Assets is expected to decline to -0.26. In addition to that, Return On Capital Employed is expected to decline to -0.55. At present, Wave Life's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 3.66, whereas Other Assets are forecasted to decline to about 4.1 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.74 | 2.30 | |
| Tangible Book Value Per Share | 1.74 | 2.32 | |
| Enterprise Value Over EBITDA | (12.68) | (13.32) | |
| Price Book Value Ratio | 9.39 | 8.92 | |
| Enterprise Value Multiple | (12.68) | (13.32) | |
| Price Fair Value | 9.39 | 8.92 | |
| Enterprise Value | 1.3 B | 1.4 B |
The leadership approach at Wave Life's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Technical Drivers
As of the 20th of February, Wave Life maintains the Market Risk Adjusted Performance of (0.87), mean deviation of 5.95, and Downside Deviation of 4.49. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Wave Life Sciences, as well as the relationship between them. Please check out Wave Life Sciences coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Wave Life Sciences is priced fairly, providing market reflects its latest price of 13.51 per share. Given that Wave Life Sciences has jensen alpha of 2.1, we strongly advise you to confirm Wave Life Sciences's prevalent market performance to make sure the company can sustain itself at a future point.Wave Life Sciences Price Movement Analysis
The output start index for this execution was nine with a total number of output elements of fifty-two. The Simple Moving Average indicator is calculated by adding the closing price of Wave Life for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Wave Life Sciences short-term fluctuations and highlight longer-term trends or cycles.
Wave Life Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Wave Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Wave Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Wave Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Henry Christian O over two months ago Disposition of 42000 shares by Henry Christian O of Wave Life at 5.97 subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Acquisition by Chandra Vargeese of 60000 shares of Wave Life at 2.83 subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Disposition of 46000 shares by Chandra Vargeese of Wave Life at 2.48 subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Acquisition by Chandra Vargeese of 50000 shares of Wave Life at 10.48 subject to Rule 16b-3 | ||
Adrian Rawcliffe over a year ago Acquisition by Adrian Rawcliffe of 45000 shares of Wave Life at 4.58 subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Acquisition by Chandra Vargeese of 361700 shares of Wave Life subject to Rule 16b-3 | ||
Ken Takanashi over a year ago Acquisition by Ken Takanashi of 45000 shares of Wave Life subject to Rule 16b-3 | ||
Chandra Vargeese over a year ago Sale by Chandra Vargeese of 10249 shares of Wave Life |
Wave Life Outstanding Bonds
Wave Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Wave Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Wave bonds can be classified according to their maturity, which is the date when Wave Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Wave Life Predictive Daily Indicators
Wave Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Wave Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Wave Life Corporate Filings
13A | 12th of February 2026 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 11th of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 5th of February 2026 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
8K | 2nd of February 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 12th of January 2026 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 6th of January 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 15th of December 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 11th of December 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Wave Life Forecast Models
Wave Life's time-series forecasting models are one of many Wave Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Wave Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Wave Life Bond Ratings
Wave Life Sciences financial ratings play a critical role in determining how much Wave Life have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Wave Life's borrowing costs.| Piotroski F Score | 2 | Frail | View |
| Beneish M Score | (10.89) | Unlikely Manipulator | View |
Wave Life Sciences Debt to Cash Allocation
Many companies such as Wave Life, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Wave Life Sciences has 25.4 M in debt with debt to equity (D/E) ratio of 1.02, which is OK given its current industry classification. Wave Life Sciences has a current ratio of 2.45, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Wave to invest in growth at high rates of return. Wave Life Total Assets Over Time
Wave Life Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Wave Life uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Wave Life Debt Ratio | 7.88 |
Wave Life Corporate Bonds Issued
Most Wave bonds can be classified according to their maturity, which is the date when Wave Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Wave Short Long Term Debt Total
Short Long Term Debt Total |
|
About Wave Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Wave Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Wave shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Wave Life. By using and applying Wave Stock analysis, traders can create a robust methodology for identifying Wave entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.81) | (0.85) | |
| Operating Profit Margin | (0.92) | (0.96) | |
| Net Loss | (0.81) | (0.85) | |
| Gross Profit Margin | (4.97) | (5.22) |
Current Wave Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Wave analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Wave analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Consensus | # of Analysts | |
| 33.38 | Strong Buy | 13 | Odds |
Most Wave analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Wave stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Wave Life Sciences, talking to its executives and customers, or listening to Wave conference calls.
Wave Stock Analysis Indicators
Wave Life Sciences stock analysis indicators help investors evaluate how Wave Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Wave Life shares will generate the highest return on investment. By understating and applying Wave Life stock analysis, traders can identify Wave Life position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 204.1 M | |
| Common Stock Shares Outstanding | 138.3 M | |
| Total Stockholder Equity | 209.5 M | |
| Total Cashflows From Investing Activities | -938 K | |
| Property Plant And Equipment Net | 28 M | |
| Cash And Short Term Investments | 302.1 M | |
| Cash | 302.1 M | |
| Accounts Payable | 16.3 M | |
| Net Debt | -276.7 M | |
| 50 Day M A | 14.661 | |
| Total Current Liabilities | 111 M | |
| Other Operating Expenses | 218.7 M | |
| Non Current Assets Total | 31.8 M | |
| Non Currrent Assets Other | 3.8 M | |
| Stock Based Compensation | 13.1 M |
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |